Apollo Medical Holdings Investor Presentation Deck
ApolloMed investment highlights
Ⓒ
Mi
01
apollomed
1.
2. Large and growing TAM with significant whitespace ahead across market segments (see slide 10)
Proven model for 25+ years with demonstrable clinical outcomes across all populations
MA, Managed Medicaid, Commercial, ACA Exchange, Medicare FFS, etc.
Focus on aligning with and helping independent providers win
3. Help them achieve the same scale and outcomes as an integrated delivery system
• Unlocks differentiated independent provider market
5.
4. Proprietary technology platform with data moat, custom built for providers
Multiple drivers for growth with a scalable and repeatable playbook led by differentiated
leadership team
Industry-leading unit economics - growing revenue at 38% YoY(1) profitably while
maintaining positive EBITDA margins
(1) ApolloMed YE2021 to mid-point of YE2022E revenue growth
6.
4View entire presentation